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p-value= 0.33); however the likelihood of receiving BCS was lower in non-SNP DEs 
than in both non-DEs (OR: 0.81, p-value< 0.0001) and D-SNPs (OR: 0.76, p-value= 
0.0002). CONCLUSIONS: The probability of receiving BCS was lower in dual members 
not in a D-SNP plan than in duals enrolled in D-SNP plans and non-DE populations. 
There was no significant difference in the probability between D-SNP and non-DE 
populations. The findings indicate that SNP plans produce better results in dual 
members compared to duals not in a SNP plan. This provides evidence of the value 
of SNP plans in achieving better outcomes for the vulnerable DE MA population.
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OBJECTIVES: Asthma holds considerable risk for developing lung cancer. It can 
be assumed that asthma has an effect on hospitalizations and healthcare costs 
accrued by lung cancer patients. This study looks at differences in patient char-
acteristics, healthcare utilizations and costs between lung cancer patients with 
asthma and without asthma. METHODS: The study used 2010 Seer-Medicare reg-
istry and hospitalization data for cancer sites lung, bronchus and not otherwise 
specified lung cancer to look at patient characteristics and measures of health 
service utilizations and costs. Two patient groups were formed based on having any 
or no asthma diagnosis during hospitalization. Descriptive statistics like frequency, 
percentage, mean and standard deviation were used to characterize differences in 
patient demographics, cancer histology, service utilization and costs between the 
two groups. RESULTS: In the prevalence sample of 14371 cases, 508 patients had a 
diagnosis of asthma. Patient characteristics like gender female (66.34% vs 49.34%), 
race African American (18.11% vs 10.86%), residence in big metropolis (56.69% vs 
51.40%) and histology squamous cell carcinoma (24.41% vs 22.31%) showed differ-
ences in presence of asthma in the population. Asthmatics (mean: 7.29 days; SD: 
13.70) had lower mean length of stay when compared to non-asthmatics (mean: 
8.56 days; SD: 16.73). Asthmatics had more intermediate inpatient intensive care 
use (54.55% vs 52.18%) and had more pharmacy costs (mean: $4853.53; SD: 11038.30 
vs mean: $4167.20; SD: 6132.22) and outpatient costs (mean: $11.59; SD: 237.65 vs 
mean: $5.26; SD: 90.40) when compared to non-asthmatics. CONCLUSIONS: There 
are subtle differences in patient characteristics, healthcare utilization and costs 
between lung cancer with asthma and without asthma. Intuitively, utilizations and 
costs should be more abundant in asthmatics. However, our study suggests that this 
variation may not be marked across all utilization and cost measures.
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OBJECTIVES: Research indicates that waste and inefficiency consumes 10% to 30% 
of health care spending, but exactly what health care interventions are contributing 
the most to this misallocation is poorly understood. Some “low-value” interventions 
that offer relatively low or no additional health benefits for their costs have been 
identified in comparative effectiveness and cost-effectiveness literature. Our study 
aims to quantify the healthcare resources and expenditures spent on low-value 
interventions in Massachusetts (MA) in an effort to better understand and allocate 
healthcare spending. For this abstract we present results for the use of arthro-
scopic surgery for knee osteoarthritis. METHODS: We identified a list of low-value 
services based on published literature, which included arthroscopic debridement/
chondroplasty for knee osteoarthritis (procedure codes: 29877, 29879, and G0289). We 
used the 2012 MA All Payer Claims Database (APCD) to examine the proportion and 
characteristics of the individuals who received these services, and to calculate the 
state’s associated annual healthcare expenditure. The APCD included medical and 
pharmacy claims from all commercial payers and certain public programs (Medicare 
Part C only and Medicaid), including patient out-of-pocket payments. RESULTS: 
From our study population (N= 6,549,289), a total of 8,488 individuals were identi-
fied as receiving arthroscopic knee surgery in 2012. Of these patients 52.5% were 
aged < 50 years, and 52% were female. Total state healthcare spending associated 
with this procedure in 2012 was $8.7 million, 95% of which were spent by private 
payers. Most (64%) of the resources were utilized in the outpatient setting, followed 
by other sites of service (non-inpatient and non-outpatient, such as swing-bed and 
ambulatory surgical center) (27%). CONCLUSIONS: Quantifying the resources spent 
on low value interventions can help decision makers gain insight on the potential 
healthcare savings that could be accrued if healthcare resources were reallocated 
away from these interventions.
PHS126
iS viSUal imPairement aSSociateD witH increaSeD HoSPitalization? 
a retroSPective coHort StUDy of commUnity-Dwelling meDicare 
beneficiareS
Tsang Y., Tom S., Onukwugha E.
University of Maryland School of Pharmacy, Baltimore, MD, USA
OBJECTIVES: Visual impairment (VI) is related to poor health outcomes such as dif-
ficulty with everyday activities, falls, and fracture. However, it is unclear whether VI 
is associated with increased hospitalization. The objective of the study is to deter-
mine whether higher levels of VI are associated with increased rates of hospitaliza-
tion. METHODS: We used a retrospective cohort study design. The Medicare Current 
Beneficiary Survey (MCBS) data covering the 2005 to 2010 time period were used to 
identify community-dwelling beneficiaries, 65 years old and older who provided 
population, while also revealing the potential limitations of the model in response 
to a sudden influx of heavy utilizers.
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OBJECTIVES: In preparation of the self-administered HPV test in Argentina, the 
goal of this paper is to document the Federal Program for the Prevention of Cervix-
Uterus Cancer (PNPCCU) operation at the first level of care and its upstream 
linkages at the secondary and tertiary levels, identifying process and outputs indi-
cators. METHODS: The project designed and implemented a series of question-
naires distributed to the local Ministry of Health, each one of its four Programmatic 
Regions, a sample of 111 health care centers (CAPs), cito/colposcopy labs and gyne-
cology services in charge of treating cancer. Information about procedures to take 
Papanoicolau samples, submit them to labs, receive results and communicate them 
to patients was collected. Descriptive statistics, robust MLS and logistics regressions 
were used to analyze the dataset. RESULTS: The outreach activities through sani-
tary agents have a potential deficit in capturing eligible women (35-60 years old). 
Although 63,6-70% of CAPs reports systematic mechanisms to submit Pap samples 
to labs according to norm, strong idiosyncratic-informal criteria prevail, with mix 
effects on efficacy in outputs. A significant proportion of centers are not able to meet 
PNPCCU recommendation of a maximum four-week time-span between samples is 
taken at CAPs and results reach patients. Time gaps (one-to-four weeks) are found 
across regions between the time abnormal results are identified and treatments are 
initiated. Besides, coverage of such cases is completely addressed and dropout rates 
are nil. CONCLUSIONS: The econometric analysis provides insights about the poor 
influence of context variables on process indicators (Paps performed, and number of 
weeks since sample is performed and results reach the patient). Also, the analysis 
identifies that the reduction of idle-times in identification and communication as 
well the improvement of equitable results are under the span of action of CAPs and 
the coordination of the primary level’s health care network.
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OBJECTIVES: Even though stillbirths audit improves healthcare quality, it is 
invisible in global policy prioritization (UNICEF, 2009) as its not counted in local 
data collection. This study assessed deployment of novel stillbirth audit tool in 
Ghana. METHODS: A standardized Stillbirth audit tool and protocol developed by 
the Regional audit task group using the Vanotoo design, Ghana Maternal death 
Notification form and Perinatal Society of Australia and New Zealand perinatal 
death guidelines. District and audit committees were formed and trained. The tool 
was deployed from January 2014 in the Greater Accra Region. Census of all audited 
stillbirths in 2014 was made. Data on total stillbirth and deliveries abstracted from 
District Health Information Management System 2. Data entered and analyzed in 
Epi info 7. RESULTS: Total of 109,187 deliveries with 2087 stillbirths (19.1 stillbirths 
per 1000 deliveries) was documented. Fifty eight percent were macerated, 42 percent 
were fresh. Only 6.4 percent of documented stillbirths were audited of which 50.0 
percent were macerated stillbirth, 46.0 percent were fresh and 62 percent females. 
Ninety three percent had ANC attendants’ mothers with 47.7 percent booking by the 
end of second trimester. Fifty seven percent had folic acid in first trimester and 40.3 
percent completed IPT-Sulfadoxine/Pyrimethamine prophylaxis. The birth weight 
ranged 0.5 to 5.0 Kg with mean 2.8± 0.9, median 3.0 and modal weight of 3.0 Kg, sixty 
nine percent had birth weights greater ≥ 2.5Kg. Birth asphyxia caused 41 percent 
of the audited deaths and 26.9 percent unknown causes. Poor management, lack of 
expertise and inadequate human resources were identified as contributory factors 
and only 32.2 percent were monitored with partograph. CONCLUSIONS: The impor-
tance of introducing the novel stillbirth audit in the Greater Accra region cannot be 
overemphasized however, findings underscore the need to enforce implementation 
since majority (93.6 percent) of stillbirths were not audited.
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OBJECTIVES: To examine differences in the likelihood of receiving Breast Cancer 
Screening (BCS) among Medicare Advantage (MA) dual eligibles (DE) enrolled in 
Special Need Plans (D-SNPs), DE in non-SNPs (non-SNP DEs), and non-DE mem-
bers. METHODS: This study used a large nationally representative administrative 
claims database supplemented with socioeconomic and community resource data. 
The sample consisted of female MA enrollees aged 50-74 years in 2013. The outcome 
of interest was an indicator of receiving BCS based on the measure definition in 
the Healthcare Effectiveness Data and Information Set. Generalized linear mixed 
model was used to compare the likelihood of receiving BCS in the three groups 
after controlling for confounding factors (i.e., demographics, comorbidities, socio-
economic characteristics and community healthcare resources) and accounting 
for unmeasured plan characteristics as a random component. RESULTS: A total 
of 258,807 MA members were included in the study (non-DE: 76.0%, non-SNP DEs: 
10.1%, D-SNP: 13.9%). BCS rates were significantly different across all three groups 
(p-value< 0.0001). The non-DE population had higher rates (77.3%) compared to both 
non-SNP DE (72.9%) and D-SNP (76.3%). The model revealed there was no significant 
difference in the likelihood of receiving BCS between D-SNPs and non-DEs (OR: 1.1, 
